Literature DB >> 1485812

IgG and IgM anti-snRNP reactivity in sequentially obtained serum samples from patients with connective tissue diseases.

U Nyman1, I Lundberg, E Hedfors, M Wahren, I Pettersson.   

Abstract

Sequentially obtained serum samples from 30 patients with connective tissue disease positive for antibody to ribonucleoprotein (RNP) were examined to determine the specificities of IgG and IgM antibodies to snRNP during the disease course using immunoblotting of nuclear extracts. The antibody patterns were correlated with disease activity. The patterns of antibody to snRNP of individual patients were mainly stable during the study but changes in levels of antibody to snRNP were seen corresponding to changes in clinical activity. These results indicate that increased reactivity of serum IgM antibodies against the B/B' proteins seems to precede a clinically evident exacerbation of disease whereas IgG antibody reactivity to the 70 K protein peaks at the time of a disease flare.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485812      PMCID: PMC1004925          DOI: 10.1136/ard.51.12.1307

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides.

Authors:  Y Takeda; G S Wang; R J Wang; S K Anderson; I Pettersson; S Amaki; G C Sharp
Journal:  Clin Immunol Immunopathol       Date:  1989-02

2.  The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases.

Authors:  D J de Rooij; L B van de Putte; W J Habets; A L Verbeek; W J van Venrooij
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

3.  Detection of nuclear antigens recognized by human autoantibodies.

Authors:  W J van Venrooij; W J Habets
Journal:  Scand J Rheumatol Suppl       Date:  1985

4.  Isolation of small nuclear ribonucleoproteins containing U1, U2, U4, U5, and U6 RNAs.

Authors:  M Hinterberger; I Pettersson; J A Steitz
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

5.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

6.  Recombinant 70-kD protein used for determination of autoantigenic epitopes recognized by anti-RNP sera.

Authors:  U Nyman; I Lundberg; E Hedfors; I Pettersson
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

7.  Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease.

Authors:  N McHugh; I James; P Maddison
Journal:  J Rheumatol       Date:  1990-10       Impact factor: 4.666

8.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.

Authors:  I Lundberg; E Hedfors
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

10.  Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis.

Authors:  M Reichlin; W J Van Venrooij
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

View more
  3 in total

1.  Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies.

Authors:  D Villalta; N Bizzaro; S Platzgummer; A Antico; M Tampoia; L Camogliano; D Bassetti; M Pradella; A Piazza; F Manoni; R Tozzoli; E Tonutti
Journal:  Clin Rheumatol       Date:  2004-12-10       Impact factor: 2.980

2.  Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.

Authors:  A Ghirardello; A Doria; P Vesco; E Vaccaro; C Bernardi; C Catani; U Fagiolo; P F Gambari
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.

Authors:  S Brauner; M Ivanchenko; G E Thorlacius; A Ambrosi; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-10-16       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.